Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

645 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.
Yacyshyn BR, Chey WY, Goff J, Salzberg B, Baerg R, Buchman AL, Tami J, Yu R, Gibiansky E, Shanahan WR; ISIS 2302-CS9 Investigators. Yacyshyn BR, et al. Among authors: goff j. Gut. 2002 Jul;51(1):30-6. doi: 10.1136/gut.51.1.30. Gut. 2002. PMID: 12077088 Free PMC article. Clinical Trial.
Enhancing the control of respiratory virus spread: a comprehensive approach integrating airborne virus detection, aerological investigations, and airflow modeling for practical implementation.
Mellon G, Mahjoub N, Metivier F, Osinski N, Gabassi A, Delaugerre C, Vanoli E, Crawford C, Le Goff J. Mellon G, et al. Among authors: le goff j. Infect Control Hosp Epidemiol. 2025 Jan 10:1-10. doi: 10.1017/ice.2024.217. Online ahead of print. Infect Control Hosp Epidemiol. 2025. PMID: 39791341
Monitoring SARS-CoV-2 variants with complementary surveillance systems: risk evaluation of the Omicron JN.1 variant in France, August 2023 to January 2024.
Traore A, Charniga K, Grellet S, Terpant G, Da Cruz H, Lamy A, Thomas N, Gbaguidi G, Mercier A, Prudhomme J, Visseaux B, Vieillefond V, Haim-Boukobza S, Giannoli JM; RELAB Study Group; Laboratory group; Castro-Alvarez J, Kouamen AC, Rameix-Welti MA, Beirrera-Ibraim S, Destras G, Josset L, Cauchemez S, Lina B, Coignard B, Schaeffer J, Enouf V, Bal A; Members of the Laboratory Group; Members of the RELAB Study Group. Traore A, et al. Euro Surveill. 2025 Jan;30(1):2400293. doi: 10.2807/1560-7917.ES.2025.30.1.2400293. Euro Surveill. 2025. PMID: 39790077 Free PMC article.
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024.
Moisan A, Regue H, Rahou Y, Gaymard A, Oblette A, Avon L, Bergaud N, Chalvignac R, Le Hingrat Q, Burrel S, Jary A, Colson P, Cappy P, Deroche L, Brodard V, Pronier C, Alessandri-Gradt E, Salmona M, Chollet L, Trémeaux P, Handala L, Fourati S, Lina B, Casalegno JS, Rameix-Welti MA, Josset L, Bal A; collaborative group; Bichat; Houhou N, Guilbaud R, Saint-Joannis T; Bordeaux; La Pitié-Salpêtrière; Marseille; Mondor; Reims; Rennes; Rouen; Saint-Louis; Toulon; Poggi C, Toyer AL, Domine M, Gardan V; Toulouse; Carcenac R, Demmou S, Latour J, Vellas C; Tours; Lyon; Pasteur; ANRS-MIE Technology working group. Moisan A, et al. Clin Microbiol Infect. 2024 Dec 24:S1198-743X(24)00605-0. doi: 10.1016/j.cmi.2024.12.018. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39725080 No abstract available.
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.
Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA; POLYRES investigators. Fourati S, et al. Lancet Infect Dis. 2024 Oct 14:S1473-3099(24)00570-X. doi: 10.1016/S1473-3099(24)00570-X. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39419046
645 results